TG
GH icon

TCW Group’s Guardant Health GH Stock Holding History

TCW Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,120
Closed -$217K – 643
2025
Q4 		$217K Buy
+2,120
New +$190K ﹤0.01% 627
2024
Q4 		– Sell
-43,799
Closed -$1M – 364
2024
Q3 		$1M Sell
43,799
-8,285
-16% -$234K 0.01% 302
2024
Q2 		$1.5M Sell
52,084
-38,090
-42% -$887K 0.01% 288
2024
Q1 		$1.86M Sell
90,174
-43,486
-33% -$932K 0.02% 250
2023
Q4 		$3.62M Buy
133,660
+25,231
+23% +$662K 0.04% 210
2023
Q3 		$3.21M Buy
108,429
+39,677
+58% +$1.4M 0.04% 193
2023
Q2 		$2.46M Buy
68,752
+1,143
+2% +$32.8K 0.03% 223
2023
Q1 		$1.58M Buy
67,609
+39,438
+140% +$1.13M 0.02% 232
2022
Q4 		$766K Buy
+28,171
New +$1.29M 0.01% 267
2021
Q2 		– Sell
-54,837
Closed -$8.37M – 347
2021
Q1 		$8.37M Buy
+54,837
New +$8.29M 0.08% 161

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCW Group's GH Position: Q1 2026 in Review

TCW Group sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,120 shares — an estimated $217K sold.

TCW Group first reported a position in GH in Q1 2021 and held it in 10 quarters. The position peaked at $8.37M in Q1 2021. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • TCW Group reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • TCW Group sold 2,120 Guardant Health shares in Q1 2026, an estimated $217K.
  • TCW Group first reported a position in Guardant Health in Q1 2021 and held it in 10 quarters.
  • TCW Group's Guardant Health position peaked at $8.37M in Q1 2021.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.